Recce Pharmaceutical Limited has updated its Corporate Governance Statement, disclosing its adherence to ASX Corporate Governance Council recommendations and detailing its governance practices. The company has outlined its commitment to corporate governance, including diversity policies, ethical conduct, and risk management.
Material actions and disclosures
Recce Pharmaceutical Limited has disclosed its adherence to the ASX Corporate Governance Council’s recommendations, including the establishment of a board charter, a code of conduct, and a whistleblower policy. The company has also detailed its processes for evaluating the performance of the board and senior executives.
Recce Pharmaceutical Limited has also disclosed its policies for remuneration, risk management, and internal controls, as well as its approach to continuous disclosure and communication with security holders.
The company has stated that it does not have an internal audit function but has disclosed the processes it employs for evaluating and continually improving the effectiveness of its risk management and internal control processes.
Recce Pharmaceutical Limited has also disclosed whether it has any material exposure to environmental or social risks and how it manages or intends to manage those risks.
These disclosures are detailed in the company’s Corporate Governance Statement, which is available on pages 40-51 of the annual report and on the company’s website.